HERON THERAPEUTICS, INC. /DE/ Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2012 to Q2 2024.
  • Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.57M, a 67.1% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $19M, a 56.5% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2023 was $32.9M, a 23.6% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2022 was $43M, a 8.26% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2021 was $46.9M, a 6.71% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $19M $4.57M -$9.33M -67.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $28.3M $3.38M -$4.57M -57.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $32.9M $4.32M -$6.19M -58.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $39M $6.68M -$4.52M -40.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $43.6M $13.9M +$3.55M +34.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $40M $7.95M -$2.97M -27.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $43M $10.5M -$2.37M -18.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $45.4M $11.2M -$38K -0.34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $45.4M $10.4M -$888K -7.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $46.3M $10.9M -$571K -4.97% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $46.9M $12.9M -$3.15M -19.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $50M $11.2M +$141K +1.27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $49.9M $11.2M +$127K +1.14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $49.7M $11.5M -$488K -4.08% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $50.2M $16M +$4.94M +44.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $45.3M $11.1M +$1.39M +14.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $43.9M $11.1M -$1.59M -12.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $45.5M $12M -$5.93M -33.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $51.4M $11.1M +$1.3M +13.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $50.1M $9.7M +$1.65M +20.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $48.5M $12.7M +$4.89M +62.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $43.6M $17.9M +$10.2M +132% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $33.4M $9.8M +$2.9M +42.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $30.5M $8.05M +$574K +7.68% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $29.9M $7.82M -$329K -4.04% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $30.2M $7.7M -$320K -3.99% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $30.5M $6.89M -$368K -5.07% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $30.9M $7.48M -$35K -0.47% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $30.9M $8.15M +$2.32M +39.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $28.6M $8.02M +$2.67M +49.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $26M $7.26M +$1.41M +24.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $24.5M $7.51M +$4.69M +166% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $19.9M $5.83M +$2.69M +85.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $17.2M $5.36M +$2.8M +110% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $14.4M $5.85M +$3.59M +159% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $10.8M $2.82M +$1.06M +60.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $9.71M $3.14M +$2.06M +191% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $7.65M $2.55M -$418K -14.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $8.07M $2.26M -$299K -11.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $8.37M $1.76M -$2.34M -57% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $10.7M $1.08M -$1.32M -55.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $12M $2.97M +$1.13M +61.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $10.9M $2.56M +$598K +30.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $10.3M $4.1M +$2.12M +107% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $8.18M $2.4M +$1.39M +137% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $6.79M $1.84M +$1.06M +136% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $5.73M $1.96M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $1.98M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.02M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $778K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.